Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
36 hedge funds and large institutions have $37.8M invested in Histogen Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
40% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 10
6% more funds holding
Funds holding: 34 → 36 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less capital invested
Capital invested by funds: $45.5M → $37.8M (-$7.69M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Polar Capital
London,
United Kingdom
|
+$1.36M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$594K |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$399K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$193K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$160K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$359K |
| 2 |
Millennium Management
New York
|
-$308K |
| 3 |
Morgan Stanley
New York
|
-$284K |
| 4 |
Goldman Sachs
New York
|
-$157K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$59.1K |
HSTO Hedge Fund Activity: Q4 2013 in Review
36 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q4 2013, worth a combined $37.8M — down 17% from $45.5M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new HSTO positions and 2 closed out — a net gain of 2 holders — while 14 added to existing stakes and 10 trimmed.
The largest buyer was Polar Capital, adding an estimated $1.36M. The largest seller was Weiss Multi-Strategy Advisers, cutting an estimated $359K.
- 36 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q4 2013, up from 34 in Q3 2013.
- Funds reported $37.8M of Histogen Inc. Common Stock stock for Q4 2013, down 17% quarter-over-quarter.
- 4 funds opened new Histogen Inc. Common Stock positions in Q4 2013 and 2 closed out, a net change of +2 holders.
- The largest Histogen Inc. Common Stock buyer in Q4 2013 was Polar Capital, an estimated $1.36M added.
- The largest Histogen Inc. Common Stock seller in Q4 2013 was Weiss Multi-Strategy Advisers, an estimated $359K sold.
Based on aggregated 13F filings for Q4 2013.